Membrane potential of mesenteric artery from carvedilol-treated spontaneously hypertensive rats

European Journal of Pharmacology

Volumn 344, Issue 2-3, 1998, Pages 161-168

  Shimamura, Keiichi ^a   Sekiguchi, Fumiko ^a   Matsuda, Kyoko ^a   Yamamoto, Kazuo ^a   Tanaka, Shoko ^a   Sunano, Satoru ^a   Shibutani, Tomoko ^b   Hashimoto, Hiroo ^b   Tanaka, Makoto ^b  

^a KINKI UNIVERSITY   (Japan)

^b DAIICHI SANKYO CO   (Japan)

Author keywords

Carvedilol; Endothelium; Membrane potential; Mesenteric artery; Noradrenaline; Smooth muscle; Spontaneously hypertensive rat, stroke prone (SHRSP)

Indexed keywords

ACETYLCHOLINE; CARVEDILOL; NORADRENALIN;

ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; HYPERPOLARIZATION; HYPERTENSION; MALE; MEMBRANE; MEMBRANE POTENTIAL; MESENTERIC ARTERY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SCANNING ELECTRON MICROSCOPY; SMOOTH MUSCLE; SPONTANEOUSLY HYPERTENSIVE RAT; VASODILATATION;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BODY WEIGHT; CARBAZOLES; ENDOTHELIUM, VASCULAR; MALE; MEMBRANE POTENTIALS; MESENTERIC ARTERIES; MUSCLE, SMOOTH, VASCULAR; PROPANOLAMINES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; VASODILATOR AGENTS;

EID: 0032485280     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01573-2     Document Type: Article

References (31)

1. +]: A functional approach to separating EDHF- and EDNO-related mechanisms in perfused rat mesenteric arterial bed. J. Cardiovasc. Pharmacol. 21, 423-429.
2. Barone, F.C., Nelson, A.H., Ohlstein, E.H., Willette, R.N., Sealey, J.E., Laragh, J.H., Campbell, Jr., W.G. Feuerstein, G.Z., 1996. Chronic carvedilol reduces mortality and renal damage in hypertensive stroke-prone rats. J. Pharmacol. Exp. Ther. 279, 948-955.
3. Bolton, T.B., Lang, R.J., Takewaki, T., 1984. Mechanisms of action of noradrenaline and carbachol on smooth muscle of guinea pig anterior mesenteric artery. J. Physiol. 351, 549-572.
4. Cheung, D.W., 1989. Vascular neuroeffector mechanisms in hypertension. Can. J. Physiol. Pharmacol. 67, 1146-1150.
5. Christensen, K.L., Mulvany, M.J., 1993. Mesenteric arcade arteries contribute substantially to vascular resistance in conscious rats. J. Vasc. Res. 30, 73-79.
6. Clozel, M., Kuhn, H., Hefti, F., 1990. Effects of angiotensin converting enzyme inhibitors and of hydralazine on endothelial function in hypertensive rats. Hypertension 16, 532-540.
7. Dunn, C.J., Lea, A.P., Wagstaff, A.J., 1997. Carvedilol: A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders. Drugs 54, 161-185.
8. Fujii, K., Tominaga, M., Ohmori, S., Kobayashi, K., Koga, T., Takata, Y., Fujishima, F., 1992. Decreased endothelium-dependent hyperpolarization to acetylcholine in smooth muscle of the mesenteric artery of spontaneously hypertensive rats. Circ. Res. 70, 660-669.
9. 2+ transients in guinea-pig coronary myocytes. J. Physiol. 470, 35-44.
10. Garland, C.J., McPherson, G.A., 1992. Evidence that nitric oxide dose not mediate the hyperpolarization and relaxation to acetylcholine in the rat small artery. Br. J. Pharmacol. 105, 429-435.
11. Garland, C.J., Plane, F., Kemp, B.K., Cocks, T.M., 1995. Endothelium-dependent hyperpolarization: A role in the control of vascular tone. Trends Pharmacol. Sci. 16, 23-30.
12. Hashimoto, H., Tanaka, M., Kanda, A., Akashi, A., 1988. Analysis of the mechanism underlying the vasodilator action of carvedilol in pithed spontaneously hypertensive rats. Drugs 36 (Suppl. 6), 31-36.
13. Hashimoto, H., Kanda, A., Hubo, H., Tanaka, M., 1991. Features of the acute hypotensive action of carvedilol and its ameliorating effect on myocardial ischemia. J. Cardiovasc. Pharmacol. 18 (Suppl. 4), S22-S28.
14. + channels which contribute to the acetylcholine-induced hyperpolarization in smooth muscle of the guinea-pig submucosal arteriole. J. Physiol. 501, 319-329.
15. Itoh, T., Seki, N., Suzuki, S., Ito, S., Kajikuri, J., Kuriyama, H., 1992. Membrane hyperpolarization inhibits agonist-induced synthesis of inositol 1,4,5-trisphosphate in rabbit mesenteric artery. J. Physiol. 451, 307-328.
16. Kreulen, D.L., Keef, K.D., 1989. Electrophysiological and neuromuscular relationships in extramural blood vessels. In: Wood, J.D. (Ed.), Handbook of Physiology. American Physiological Society, Baltimore, pp. 1605-1634.
17. Kuriyama, H., Kitamura, K., Nabana, H., 1995. Pharmacological and physiological significance of ion channels and factors that modulate them in vascular tissues. Pharmacol. Rev. 47, 387-573.
18. Mulvany, M.J., Aalkjaer, C., 1990. Structure and function of small arteries. Physiol. Rev. 70, 921-961.
19. Nelson, M.T., Patlak, J.B., Worley, J.F., Standen, N.B., 1990. Calcium channels, potassium channels and voltage dependence of arterial smooth muscle cell tone. Am. J. Physiol. 259, C3-C18.
20. Nigro, D., Fortes, Z.B., Carvalho, M.H.C., Scivoletto, R., 1989. Chronic but not acute treatment with hydralazine reserves the decreased endothelium-dependent response in spontaneously hypertensive rats. Clin. Exp. Hypertension A 11, 573-586.
21. Okamoto, K., Yamori, Y., Nagaoka, A., 1974. Establishment of the stroke-prone spontaneously hypertensive rat (SHR). Circ. Res. 34/35 (Suppl.), 143-153.
22. Osol, G., 1995. Mechanotransduction by vascular smooth muscle. J. Vasc. Res. 32, 275-292.
23. Prichard, B.N.C., 1992. β-blocking agents with vasodilating action. J. Cardiovasc. Pharmacol. 19 (Suppl. 1), S1-S4.
24. Rahn, K.H., 1987. Antihypertensive compounds with combined actions. J. Cardiovasc. Pharmacol. 10 (Suppl. 11), S18-S22.
25. Seki, N., Nagao, T., Komori, K., Suzuki, H., 1988. Alpha and beta-adrenoceptor blocking action of carvedilol in the canine mesenteric artery and vein. J. Pharmacol. Exp. Ther. 246, 1116-1122.
26. Shimamura, K., Zou, L.-B., Moriyama, K., Yamamoto, K., Sekiguchi, F., Sunano, S., 1997. Effects of amiloride on the neurally mediated contraction of mesenteric artery. Eur. J. Pharmacol. 320, 37-42.
27. Sponer, G., Bartsch, W., Strein, K., Muller-Beckmann, B., Bohm, E., 1987. Pharmacological profile of carvedilol as a β-blocking agent with vasodilating and hypotensive properties. J. Cardiovasc. Pharmacol. 9, 317-327.
28. Sunano, S., Itoh, H., Isogai, N., Osugi, S., Yamamoto, K., Shimamura, K., 1993. Effects of antihypertensive treatment on endothelial structure and endothelium-dependent relaxation in aorta of stroke-prone spontaneously hypertensive rats. J. Vasc. Med. Biol. 4, 235-242.
29. Sunano, S., Sekiguchi, F., Nakamura, A., Matsuda, K., Yamamoto, K., Shibutani, T., Hashimoto, H., Tanaka, M., Shimamura, K., 1997. Effects of chronic treatment with carvedilol on smooth muscle tone and endothelium-dependent relaxation of aorta in stroke-prone spontaneously hypertensive rats. J. Smooth Muscle Res. 33, 23-35.
30. Watt, P.A.C., Thurston, H., 1989. Endothelium-dependent relaxation in resistance vessel from the spontaneously hypertensive rats. J. Hypertension 7, 661-666.
31. Yue, T.L., Cheng, H.Y., Lysko, P.G., McKenna, P.J., Feuerstein, R., Gu, J.L., Lysco, K.A., Davis, L.L., Feuerstein, G.Z., 1992. Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger. J. Pharmacol. Exp. Ther. 263, 92-98.